paidContent - SEC Said To Still Be Investigating Apple Over Jobs' Health Secrecy

This story was written by Joseph Tartakoff.
Apple (NSDQ: AAPL) CEO Steve Jobs is back at work, but the company still can’t shake questions about whether it may have misled investors about the status of his health. Seven months after the SEC began an investigation into Apple Inc.‘s public comments on Jobs’s medical condition, the inquiry continues, according to Bloomberg News, which cites an unnamed source. That source adds that the continued inquiry does not necessarily imply that the SEC will take action against Apple.

Bloomberg initially reported in January that the SEC had opened an investigation. Wednesday’s piece does not provide many additional details, simply saying that a “pivotal question for regulators is what Apple’s board knew at the time of Jobs’s Jan. 5 announcement that he had a hormone imbalance and a Jan. 14 statement that he was taking a five-and-a-half month medical leave.” The news agency reports that two Apple directors had been briefed by doctors on Jobs’s condition.

A Memphis hospital said in late June that Jobs had a liver transplant—although Apple has stayed silent on what medical treatment Jobs received, simply saying, “We are very glad to have him back.”

Related


By Joseph Tartakoff